Â
UTEST Cocaine 300ng/mL Self-Testing Device
The UTEST Cocaine 300ng/mL Self-Testing Device is a convenient one-step, self-testing tool for detecting the presence of Cocaine in urine samples.
Â
Key Features:
Â
UTest High Standard Cocaine 300ng/mL is a rapid drug-screening test designed to detect cocaine-related metabolites at a cutoff concentration of 300 nanograms per milliliter (ng/mL). Commonly associated with preliminary cocaine screening, this test helps users identify whether the target analyte is present at or above the specified detection threshold. It offers a convenient option for preliminary screening, although unexpected positive results should be confirmed through an accredited laboratory. Customers in the United States and Canada should follow the manufacturer's instructions for proper testing and result interpretation.
It is a cocaine-related drug-screening test with a stated detection cutoff of 300ng/mL.
It means the test uses a cutoff concentration of 300 nanograms per milliliter for its specified target analyte.
Cocaine urine screening tests commonly detect benzoylecgonine, the primary metabolite of cocaine. The exact target analyte for this product should be confirmed on its packaging.
It is associated with cocaine metabolite screening, but the specimen type should be verified from the manufacturer's instructions.
High Standard is part of the product's designation. It should not be interpreted as proof of superior accuracy or regulatory certification without supporting documentation.
No. When testing the same analyte using comparable methods, a 150ng/mL cutoff is lower and may detect smaller concentrations than a 300ng/mL cutoff.
Accuracy depends on the manufacturer's validated performance, sample collection, storage conditions, and correct interpretation. Exact accuracy statistics have not been independently verified.
It may detect cocaine-related metabolites when their concentrations reach the specified cutoff. Detection depends on exposure history, metabolism, specimen type, and timing.
Detection windows vary by specimen type, frequency of exposure, individual metabolism, and test sensitivity. No single detection period applies to everyone.
Yes. Preliminary screening tests can produce false-positive results, which should be confirmed using an appropriate laboratory method.
Yes. A negative result may occur when the target analyte is below the cutoff or when other testing limitations affect detection.
A preliminary positive result indicates a screening reaction at the test's cutoff. It is not definitive proof of cocaine use without appropriate confirmation.
No. A valid negative result generally means the target analyte was not detected at or above the specified cutoff.
Certain substances or test-specific limitations may affect screening results. Unexpected findings should be reviewed with a qualified healthcare professional or laboratory.
The exact result-reading time should be confirmed from the manufacturer's instructions.
Rapid drug-screening tests are generally single-use devices. Confirm the manufacturer's instructions for this model.
Check the original packaging for an expiration date and lot number. Expired tests may produce unreliable results.
Follow the manufacturer's storage instructions and protect the test from moisture, extreme temperatures, and damaged packaging.
Availability depends on retailer inventory and applicable federal, state, and local requirements.
Canadian availability depends on retailer inventory, import eligibility, product classification, and applicable regulations.
A 300ng/mL cocaine drug test is a preliminary screening device that evaluates a sample against a cutoff concentration of 300 nanograms per milliliter for a specified cocaine-related analyte.
A 150ng/mL test has a lower cutoff than a 300ng/mL test. When other testing characteristics are comparable, it may detect lower analyte concentrations.
Benzoylecgonine is a common target of cocaine urine screening tests. Confirm that this specific product detects benzoylecgonine by reviewing the manufacturer's documentation.
No. A preliminary screening result cannot reliably establish the exact timing of cocaine exposure.
No. A cutoff-based screening test generally provides a qualitative result rather than an exact quantitative laboratory measurement.
It may be appropriate for home screening if the manufacturer designates it for that purpose. Follow all instructions and applicable requirements.
Suitability depends on the employer's testing program, applicable Canadian requirements, and whether the product meets the necessary standards.
Regulatory authorization has not been independently verified for this exact model. Consult official regulatory records and manufacturer documentation.
An invalid result indicates that the test did not meet its required validity criteria. Follow the manufacturer's instructions for handling invalid results.
Request confirmation through an appropriate accredited laboratory before making important medical, employment, or legal decisions.
| Feature | Information |
|---|---|
| Product Name | UTest High Standard Cocaine |
| Product Category | Cocaine-related drug-screening test |
| Stated Cutoff | 300ng/mL |
| Product Designation | High Standard |
| Target Analyte | Manufacturer confirmation required; commonly benzoylecgonine |
| Specimen Type | Manufacturer confirmation required |
| Test Format | Manufacturer confirmation required |
| Result Time | Manufacturer confirmation required |
| Package Contents | Manufacturer confirmation required |
| Regulatory Status | Not independently verified |
| Markets Addressed | United States and Canada |
Read the manufacturer's complete instructions before use. Verify the specimen type, expiration date, storage requirements, and result-reading procedure.
A preliminary positive result does not constitute a confirmed diagnosis or definitive proof of cocaine use. Unexpected positive findings should be confirmed using an appropriate laboratory method.
A negative result does not guarantee the complete absence of cocaine-related substances. Testing requirements and regulatory standards may differ between the United States and Canada.
UTest High Standard Cocaine 300ng/mL provides preliminary cocaine-related drug screening using a stated cutoff of 300ng/mL. It offers a straightforward way to evaluate a sample against a defined detection threshold while remaining subject to the limitations of rapid screening methods.
For customers in the USA and Canada, accurate testing depends on following the manufacturer's instructions and obtaining laboratory confirmation when necessary.
